Non-over-rated drug tape procurement Anhui has begun to prepare.

Recently, "Anhui Province public medical institutions clinical commonly used drug centralized drug volume procurement negotiation spending implementation plan (draft for comments)" in the industry, "draft for comments" shows that Anhui Province will further improve the non-over-rated drug centralized volume procurement negotiation bargaining mechanism, promote the normalization of the amount of procurement, reduce the price of drug procurement.
that is, Anhui Province will be commonly used in the clinical non-over-evaluation drugs to carry out the volume of procurement price negotiations, clinical use of large, high procurement amount, clinical use of more mature and a number of enterprises produced non-rated drugs will be classified as a batch of belt procurement, according to the annual total amount of 70% as the total purchase volume.
In view of the reduction of drug prices is the main goal of this volume procurement, "draft for comments" also explained that the final price will be set negotiations, this finalist price will refer to the national provincial bid price, the net limit price, the lowest price of the volume of procurement, as well as the province's public medical institutions actual purchase price of the median, average price, the lowest price and the first ticket price of the two-vote system, and finally by experts to negotiate the price of the negotiation.
finalists will negotiate a price through two rounds of expert groups, resulting in a volume purchase bargain.
the Draft for Comments also pointed out that for the winning drugs, adhere to the two-vote system, encourage a one-vote system, pharmaceutical companies can be directly distributed.
.